SkinHealth stockholders approve reverse split of 1-for-5 to 1-for-20 at September 22 special meeting

SkinHealth Systems Inc.

Proposal 1 passed with 114,398,602 votes for, 1,406,150 against and 88,570 abstentions; exact split ratio left to the board's sole discretion within the 1-for-5 to 1-for-20 range.
Proposal 2, allowing adjournment for further proxy solicitation, passed 114,344,814 for to 1,450,597 against, with 97,911 abstentions.
130,140,763 Class A shares outstanding as of the August 3, 2026 record date; 115,893,322 shares (89.05%) present virtually or by proxy, establishing a quorum.
No broker non-votes were recorded on either proposal; matters were described in the Definitive Proxy Statement on Schedule 14A filed August 12, 2026.
Filing signed by Michael Monahan, Chief Financial and Operating Officer, dated September 28, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.